Resources Contact Us Home
Modified leukotoxin protein

Image Number 10 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Focus information generating device and focus information generating method
Image forming apparatus assembled with a fixing member and a pressing member
System and method for backup communication over ethernet
System and method to assess and report the health of landing gear related components
Semiconductor device and method of manufacturing the same
Method for preparing a .beta.-SiAlON phosphor
Base station device and wireless communication method
  Randomly Featured Patents
Substituted pyrimido[6,1-a]isoquinolin-4-ones,pyrimido[6,1-a]benzozepin-4-ones and pyrimido[6,1-a]benzodiazepin-4-ones useful for prevention of thromboses and treating hypertension
Apparatus for the continuous production of foam plastic blocks of rectangular cross-section
System and method for generating a reference voltage
Video distribution device, video distribution system, and video distribution method
Easy mount picture package
Herbicidal isoxazole and 2-cyano-1,3-dione compounds
Medical probe device and method
Method for producing homo-and co-polymers of ethylene
Data value occurrence information for data compression
Recording and/or reproducing apparatus using signal processing program information